161 related articles for article (PubMed ID: 20159944)
21. Combination treatment with arsenic trioxide and phytosphingosine enhances apoptotic cell death in arsenic trioxide-resistant cancer cells.
Park MT; Kang YH; Park IC; Kim CH; Lee YS; Chung HY; Lee SJ
Mol Cancer Ther; 2007 Jan; 6(1):82-92. PubMed ID: 17237268
[TBL] [Abstract][Full Text] [Related]
22. ASK1 is activated by arsenic trioxide in leukemic cells through accumulation of reactive oxygen species and may play a negative role in induction of apoptosis.
Yan W; Arai A; Aoki M; Ichijo H; Miura O
Biochem Biophys Res Commun; 2007 Apr; 355(4):1038-44. PubMed ID: 17331470
[TBL] [Abstract][Full Text] [Related]
23. Role of the p38 mitogen-activated protein kinase pathway in the generation of the effects of imatinib mesylate (STI571) in BCR-ABL-expressing cells.
Parmar S; Katsoulidis E; Verma A; Li Y; Sassano A; Lal L; Majchrzak B; Ravandi F; Tallman MS; Fish EN; Platanias LC
J Biol Chem; 2004 Jun; 279(24):25345-52. PubMed ID: 15056660
[TBL] [Abstract][Full Text] [Related]
24. Modulation of arsenic trioxide-induced apoptosis by genistein and functionally related agents in U937 human leukaemia cells. Regulation by ROS and mitogen-activated protein kinases.
Sánchez Y; Calle C; de Blas E; Aller P
Chem Biol Interact; 2009 Nov; 182(1):37-44. PubMed ID: 19720055
[TBL] [Abstract][Full Text] [Related]
25. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer.
Maeda H; Hori S; Nishitoh H; Ichijo H; Ogawa O; Kakehi Y; Kakizuka A
Cancer Res; 2001 Jul; 61(14):5432-40. PubMed ID: 11454688
[TBL] [Abstract][Full Text] [Related]
26. BCR-ABL mediates arsenic trioxide-induced apoptosis independently of its aberrant kinase activity.
Puccetti E; Güller S; Orleth A; Brüggenolte N; Hoelzer D; Ottmann OG; Ruthardt M
Cancer Res; 2000 Jul; 60(13):3409-13. PubMed ID: 10910048
[TBL] [Abstract][Full Text] [Related]
27. Arsenic trioxide affects signal transducer and activator of transcription proteins through alteration of protein tyrosine kinase phosphorylation.
Wetzler M; Brady MT; Tracy E; Li ZR; Donohue KA; O'Loughlin KL; Cheng Y; Mortazavi A; McDonald AA; Kunapuli P; Wallace PK; Baer MR; Cowell JK; Baumann H
Clin Cancer Res; 2006 Nov; 12(22):6817-25. PubMed ID: 17121903
[TBL] [Abstract][Full Text] [Related]
28. 12-O-tetradecanoylphorbol-13-acetate may both potentiate and decrease the generation of apoptosis by the antileukemic agent arsenic trioxide in human promonocytic cells. Regulation by extracellular signal-regulated protein kinases and glutathione.
Fernández C; Ramos AM; Sancho P; Amrán D; de Blas E; Aller P
J Biol Chem; 2004 Jan; 279(5):3877-84. PubMed ID: 14610070
[TBL] [Abstract][Full Text] [Related]
29. Arsenic trioxide-mediated antiplatelet activity: pivotal role of the phospholipase C gamma 2-protein kinase C-p38 MAPK cascade.
Lin KH; Chang YF; Fan CY; Jayakumar T; Lee JJ; Chou DS; Hsiao G; Sheu JR
Transl Res; 2010 Feb; 155(2):97-108. PubMed ID: 20129490
[TBL] [Abstract][Full Text] [Related]
30. Phosphorylation of PML by mitogen-activated protein kinases plays a key role in arsenic trioxide-mediated apoptosis.
Hayakawa F; Privalsky ML
Cancer Cell; 2004 Apr; 5(4):389-401. PubMed ID: 15093545
[TBL] [Abstract][Full Text] [Related]
31. Docosahexaenoic acid enhances arsenic trioxide-mediated apoptosis in arsenic trioxide-resistant HL-60 cells.
Sturlan S; Baumgartner M; Roth E; Bachleitner-Hofmann T
Blood; 2003 Jun; 101(12):4990-7. PubMed ID: 12609832
[TBL] [Abstract][Full Text] [Related]
32. Negative regulatory effects of Mnk kinases in the generation of chemotherapy-induced antileukemic responses.
Altman JK; Glaser H; Sassano A; Joshi S; Ueda T; Watanabe-Fukunaga R; Fukunaga R; Tallman MS; Platanias LC
Mol Pharmacol; 2010 Oct; 78(4):778-84. PubMed ID: 20664001
[TBL] [Abstract][Full Text] [Related]
33. Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1.
Ling S; Xie H; Yang F; Shan Q; Dai H; Zhuo J; Wei X; Song P; Zhou L; Xu X; Zheng S
J Hematol Oncol; 2017 Feb; 10(1):59. PubMed ID: 28241849
[TBL] [Abstract][Full Text] [Related]
34. In vitro studies of the combination of imatinib mesylate (Gleevec) and arsenic trioxide (Trisenox) in chronic myelogenous leukemia.
La Rosée P; Johnson K; O'Dwyer ME; Druker BJ
Exp Hematol; 2002 Jul; 30(7):729-37. PubMed ID: 12135670
[TBL] [Abstract][Full Text] [Related]
35. JNK activation is a mediator of arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cells.
Davison K; Mann KK; Waxman S; Miller WH
Blood; 2004 May; 103(9):3496-502. PubMed ID: 14701702
[TBL] [Abstract][Full Text] [Related]
36. Novel human neutrophil agonistic properties of arsenic trioxide: involvement of p38 mitogen-activated protein kinase and/or c-jun NH2-terminal MAPK but not extracellular signal-regulated kinases-1/2.
Binet F; Girard D
J Leukoc Biol; 2008 Dec; 84(6):1613-22. PubMed ID: 18728151
[TBL] [Abstract][Full Text] [Related]
37. Osmotic stress activates the TAK1-JNK pathway while blocking TAK1-mediated NF-kappaB activation: TAO2 regulates TAK1 pathways.
Huangfu WC; Omori E; Akira S; Matsumoto K; Ninomiya-Tsuji J
J Biol Chem; 2006 Sep; 281(39):28802-10. PubMed ID: 16893890
[TBL] [Abstract][Full Text] [Related]
38. Inorganic arsenic activates reduced NADPH oxidase in human primary macrophages through a Rho kinase/p38 kinase pathway.
Lemarie A; Bourdonnay E; Morzadec C; Fardel O; Vernhet L
J Immunol; 2008 May; 180(9):6010-7. PubMed ID: 18424721
[TBL] [Abstract][Full Text] [Related]
39. Arsenic trioxide and bortezomib interact synergistically to induce apoptosis in chronic myelogenous leukemia cells resistant to imatinib mesylate through Bcr/Abl‑dependent mechanisms.
Xu W; Wei W; Yu Q; Wu C; Ye C; Wu Y; Yan H
Mol Med Rep; 2014 Sep; 10(3):1519-24. PubMed ID: 24939418
[TBL] [Abstract][Full Text] [Related]
40. Arsenic trioxide sensitizes promonocytic leukemia cells to TNFalpha-induced apoptosis via p38-MAPK-regulated activation of both receptor-mediated and mitochondrial pathways.
Amrán D; Sánchez Y; Fernández C; Ramos AM; de Blas E; Bréard J; Calle C; Aller P
Biochim Biophys Acta; 2007 Nov; 1773(11):1653-63. PubMed ID: 17673311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
